ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2018

Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease.

Francisco Navarrete et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.